当前位置：首页 > 文献互助 > 互助详情

Elderly medical patients treated with prophylactic dosages of enoxaparin: influence of renal function on anti-Xa activity level复制

用户mKQO0T3T2ANY 1个月前 49 10 已完结

1. 系统已在2025-12-02 11:46:26对应助文件进行删除

2. 如有需要请重新发布求助信息

注: 所有应助的资源仅供学习交流使用, 不得违反相关法律法规

DOI:复制

文献链接:复制

其他信息:

I Mahe, I Gouin-Thibault, L Drouet, G Simoneau…
Drugs & aging, 2007
Springer
… However, further large studies could be performed to evaluate whether monitoring anti-Xa activity would improve safety in elderly patients, especially those with bodyweight <50kg and/…

上一篇： Anti-Xa Level Monitoring in Elderly Trauma Patients Receiving Enoxaparin Prophylaxis

下一篇：Evaluating anticoagulation sensitivity among elderly patients managed with an institution’s heparin protocol using initial anti-factor Xa levels

互助时间线

2025-11-25 14:10:42 [完结求助]

楼主确认了jodie0105应助的文件是正确的, 求助状态变成 已完结

2025-11-25 11:46:26 [上传文件]

jodie0105上传了文件(pdf 145.53 KB), 求助状态变成 待确认

2025-11-25 11:22:51 [发起求助]

最新发布的求助

Expression of Type I Procollagen Genes 13分钟前
The Primary Structure of Collagen 16分钟前
Increased expression of phosphodiesterase 4 in activated hepatic stellate cells promotes cytoskeleton remodeling and cell migration 34分钟前
A mussel-inspired lignin micro-nanospheres/epoxy composite coating with superhydrophobicity, ultraviolet resistance, and photothermal conversion performance for excellent corrosion control 1小时前
Unexpected Activities of CYP152 Peroxygenases Toward Non‐carboxylic Substrates Reveal Novel Substrate Recognition Mechanism and Catalytic Versatility 1小时前
Carbon nanomaterials for non-volatile memories 1小时前
CDK3 induces neuronal death and brain atrophy in Alzheimer's disease 2小时前
Computational Screening and Experimental Validation of Inhibitor Targeting the Complex Formation of Grb14 and Insulin Receptor 2小时前
CDK3 drives neuron loss in Alzheimer’s disease 2小时前
Aprocitentan (a Dual Endothelin-Receptor Antagonist) for Treatment-Resistant Hypertension 3小时前
Gut microbiota-derived L-theanine promotes host branched-chain amino acid catabolism 3小时前
Regulatory frameworks and filing discrepancies in generic drug approvals: A cross-regional study with analysis of FDA ANDA deficiencies 3小时前

wispass工作室 Copyright © 蜀ICP备2024051606号-2 www.wispass.com